Spruson & Ferguson has a long-established leading practice in the biotechnology, pharmaceutical and life sciences sectors across Australia, Southeast Asia, Greater China and right across the Asia Pacific region. With a strong knowledge of the pharmaceutical and related industries, and a thorough understanding of the commercial and regulatory environments in which our clients operate, we ensure that our advice and services to clients in these sectors is aligned with their individual business needs, is commercially appropriate and aims to maximise their strategic IP position.
In this diverse and ever-evolving field, we specialise in the planning, creation and strategic management of patent portfolios for innovators at all stages of their development.
Who we work with
We work with start-ups, established research and development institutions, universities, co-operative research centres and multinational pharmaceutical companies across the Asia Pacific, Europe, the US and globally.
Breadth of expertise
Our patent attorneys speak the technical language of life sciences and biotechnology. The majority are qualified to PhD level in areas such as genetics, biophysics, molecular biology, microbiology, biomedical engineering, chemistry and biochemistry. We also have scientists trained in a broad range of relevant technologies including cardiovascular, immunoscience, metabolics, neuroscience, oncology and virology. Their expertise includes patent term extensions, data exclusivity, regulatory approval and all other aspects of advice relating to our client’s core commercial products.
In Australia, our patent and trade mark attorneys work alongside highly experienced specialist litigators and commercialisation experts that have acted in a number of Australia’s largest pharmaceutical litigation matters.
These factors allow us to build the right team with appropriate skill sets to match each of our clients’ needs.
Get in touch
Reach out to us any time for an assessment of your needs and services. Our latest articles are below, and you can Follow us any time on LinkedIn to stay up to date with the latest thinking.
Simon is an accomplished professional services leader, and commenced as Managing Director of Spruson & Ferguson Australia following key leadership positions as head of the Australian Chemical/Life Sciences team…
Simon is an accomplished professional services leader, and commenced as Managing Director of Spruson & Ferguson Australia following key…
Maik Brinkmann is the Life Science Practice Group Leader in Asia and his practice primarily involves the drafting and prosecution of patent applications, advice in relation to patent validity…
Maik Brinkmann is the Life Science Practice Group Leader in Asia and his practice primarily involves the drafting and…
Katrina is counted amongst Australia’s top IP litigation lawyers, with 25 years’ experience of obtaining successful outcomes for clients.
Dual qualified as a lawyer and patent attorney, patent litigation is…
Katrina is counted amongst Australia’s top IP litigation lawyers, with 25 years’ experience of obtaining successful outcomes for clients.
Dual…
Mike joined Spruson & Ferguson in October 2020 after 16 years of experience in another leading Australian IP firm.
Mike is a registered patent attorney specialising in the chemical sciences….
Mike joined Spruson & Ferguson in October 2020 after 16 years of experience in another leading Australian IP firm.
Mike…
Elizabeth joined Spruson & Ferguson’s Chemical/Life Sciences group in 2008, where she specialises in the field of pharmaceuticals.
Elizabeth assists numerous local and international clients, particularly pharmaceutical companies, in various…
Elizabeth joined Spruson & Ferguson’s Chemical/Life Sciences group in 2008, where she specialises in the field of pharmaceuticals.
Elizabeth assists…
Michael is a leading Australian patent attorney recognized for his legal acumen and his technical expertise in biotechnology, and is a member of our life sciences team.
Michael’s patent expertise…
Michael is a leading Australian patent attorney recognized for his legal acumen and his technical expertise in biotechnology, and…
Ee Lin holds a Bachelor of Technology degree with First Class Honours in Biotechnology from the University of Auckland, where, during the course of her studies, she was engaged…
Ee Lin holds a Bachelor of Technology degree with First Class Honours in Biotechnology from the University of Auckland,…
Duncan is a specialist intellectual property lawyer. He has extensive IP litigation expertise with 18 years’ experience.
Duncan’s practice focuses on patent disputes, including in the mining/energy, pharmaceutical, biotechnology, medical…
Duncan is a specialist intellectual property lawyer. He has extensive IP litigation expertise with 18 years’ experience.
Duncan’s practice focuses…
Andrew is a specialist in intellectual property disputes. His practice focuses on the life sciences.
Andrew has particular expertise in handling complex patent disputes for global leaders in the pharmaceuticals,…
Andrew is a specialist in intellectual property disputes. His practice focuses on the life sciences.
Andrew has particular expertise in…
Daniel Sieveking holds a Bachelor of Science with First Class Honours in medical microbiology and immunology from the University of New South Wales. Daniel’s doctoral studies were undertaken at…
Daniel Sieveking holds a Bachelor of Science with First Class Honours in medical microbiology and immunology from the University…
Prior to joining Spruson & Ferguson (Asia), Natsuho worked as a postdoctoral fellow at Northwestern University in Evanston, Illinois, USA where she was involved with a project on cobalt…
Prior to joining Spruson & Ferguson (Asia), Natsuho worked as a postdoctoral fellow at Northwestern University in Evanston, Illinois,…
In Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd FCAFC 161 (Otsuka v Sun Pharma), the Full Federal Court of Australia decided that Otsuka’s patent to…
In Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd FCAFC 161 (Otsuka v Sun Pharma), the…
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied a double-standard with respect to written description requirements, namely the…
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied…
For more than a century, the needle and syringe have been the standard tools of immunisation. Now, advances in engineering and formulation are driving a shift toward needle-free vaccine…
For more than a century, the needle and syringe have been the standard tools of immunisation. Now, advances in…
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past year.
The year has seen a series of landmark decisions from…
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past…
